Neurosequential Model of Therapeutics (NMT) Assessment
Program/Intervention Name
Category
Assessment and Measurement Instruments for Target Populations, Staff Training and Development, Clinical Practice Model
Program/Intervention Description
The Neurosequential Model of Therapeutics (NMT). NMT is a developmentally-informed, biologically respectful approach to working with at-risk children that helps to organize a child’s history and current functioning. Especially relevant to children and youth experiencing early trauma, NMT integrates the core principles from the fields of neurodevelopment and traumatology to determine the how the timing and severity of trauma may have influenced the development of the brain. The results help professionals and families apply interventions that are appropriately aligned with the child’s needs and strengths. NMT is not a specific intervention, rather an approach to clinical work that is informed by neuroscience (Perry, 2006).
Intervention Target Population Identified (Age Group)
0-5, 6-12, 13-17, >17, Parent/Adult
Program Goals/Outcomes
NMT helps to strengthen family relationships and improves caregiver competence and confidence. The improvement results from the organization of the child’s history and current functioning that ensures that appropriate therapeutic interventions are being chosen (assessment) and education of the caregiver on how to best support the therapeutic needs of the child in their care.
QIC Target Group
General - 3
QIC Adoption/Guardianship Relevance Levels
LEVEL 6: General Population
Intervention is being evaluated in a project site
QIC level of Evidence
LEVEL 4: Promising Practice
Intervention Web Site/URL
- promising: http://www.blueprintsprograms.com
- :
Contact Person/Purveyor
Agency/Affiliation
Contact Email
Contact Phone
External Links (Registry/Other Catalog)
Attachments
- NMT Database Overview: NMT-Database-Overview-3_16_16.pdf
- NMT Frequently Asked Questions: NMT-Site-CERT-FAQ-2_11_16.pdf
- NMT Evidence Based Practice: NMT_EBP-3_2_18.pdf
